Stockreport

Cybin spikes after FDA breakthrough tag for psychedelic therapy [Seeking Alpha]

Cybin Inc. Common Shares  (CYBN) 
PDF Food and Drug Administration (FDA) granted the breakthrough therapy designation for its psychedelic-based experimental treatment, CYB003. The designation covers CYBN's [Read more]